Mumps virus strain B level jeryl lynn live antigen

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Mumps virus strain B level jeryl lynn live antigen
Accession Number
DB10316
Description

Mumps virus strain B level jeryl lynn live antigen is a live attenuated virus vaccine for subcutenous injection. It is an active immunization against mumps, which is a common childhood disease.

Type
Biotech
Groups
Approved, Investigational
Biologic Classification
Vaccines
Attenuated
Synonyms
  • Mumps Virus Vaccine Live, Jeryl Lynn Strain

Pharmacology

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Indication
Not Available
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
M-M-R IIMumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousA-S Medication Solutions1971-04-21Not applicableUS flag
M-M-R IIMumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousPhysicians Total Care, Inc.1996-08-072012-06-30US flag
M-M-R IIMumps virus strain B level jeryl lynn live antigen (12500 TCID50/0.5mL) + Measles virus vaccine live attenuated (1000 TCID50/0.5mL) + Rubella virus vaccine (1000 TCID50/0.5mL)Powder, for solutionSubcutaneousMerck Ltd.1979-12-31Not applicableCanada flag
M-M-R IIMumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousMerck Sharp & Dohme Corp.1971-04-21Not applicableUS flag
M-M-rvaxproMumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Measles virus vaccine live attenuated (1000 TCID50) + Rubella virus vaccine (1000 TCID50)Msd Vaccins2021-02-10Not applicableEU flag
M-M-rvaxproMumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Measles virus vaccine live attenuated (1000 TCID50) + Rubella virus vaccine (1000 TCID50)Msd Vaccins2021-02-10Not applicableEU flag
M-M-rvaxproMumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Measles virus vaccine live attenuated (1000 TCID50) + Rubella virus vaccine (1000 TCID50)Msd Vaccins2021-02-10Not applicableEU flag
M-M-rvaxproMumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Measles virus vaccine live attenuated (1000 TCID50) + Rubella virus vaccine (1000 TCID50)Msd Vaccins2021-02-10Not applicableEU flag
M-M-rvaxproMumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Measles virus vaccine live attenuated (1000 TCID50) + Rubella virus vaccine (1000 TCID50)Msd Vaccins2021-02-10Not applicableEU flag
M-M-rvaxproMumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Measles virus vaccine live attenuated (1000 TCID50) + Rubella virus vaccine (1000 TCID50)Msd Vaccins2021-02-10Not applicableEU flag

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
47QB6MX9KU
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910495
RxNav
798372

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedNot AvailableRheumatoid Arthritis, Juvenile1
4CompletedPreventionAdverse Event Following Immunization / Mumps / Rubella / Rubeola1
4CompletedPreventionBCG Infection / Immune Response / Reaction - Vaccine1
4CompletedPreventionChickenpox / Hepatitis A / Mumps / Rubella / Rubeola1
4CompletedPreventionEncephalitis, Japanese B / Mumps / Rubella / Rubeola1
4CompletedPreventionHepatitis A Virus1
4CompletedPreventionHepatitis A / Mumps / Rubella / Rubeola1
4CompletedPreventionMumps / Rubella / Rubeola2
4CompletedTreatmentHuman Immunodeficiency Virus (HIV) Infections1
4CompletedTreatmentMumps / Rubella / Rubeola / Varicella1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, powder, lyophilized, for solutionSubcutaneous
Injection, powder, lyophilized, for suspensionSubcutaneous
Injection, powder, for suspensionIntramuscular; Subcutaneous
Injection, powder, lyophilized, for solutionIntramuscular; Subcutaneous
Injection, powder, for solutionSubcutaneous
Kit; powder, for solutionIntramuscular; Subcutaneous
Injection, solutionIntramuscular; Subcutaneous
Injection, powder, for solutionIntramuscular; Subcutaneous
Injection
Injection, powder, lyophilized, for suspensionIntramuscular; Subcutaneous
Powder, for solutionSubcutaneous
Solution
InjectionSubcutaneous
Injection, powder, lyophilized, for suspension
Powder
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on December 01, 2015 20:03 / Updated on June 12, 2020 16:53